Public Market Listing
002294SZSE
Live quotes, historical charts, and market capitalization for Shenzhen Salubris Pharmaceuticals are available on Yahoo Finance.
View quote & market cap on Yahoo Finance ↗External market data link · No third-party exchange redistribution
Assets
(7 total)
7Total Assets
0Approved
3Phase 3 / Filed
4Phase 1–2 / Early
4Diseases
Quick filter:
| Target & Modality | |||
|---|---|---|---|
| Phase 3 | HIF prolyl hydroxylase (HIF-PH1/2/3)Small molecule | Chronic Kidney Disease | |
| Phase 3 | PCSK9Monoclonal antibody | Indication not yet linked | |
SAL0150No recent activity | Phase 3 | GLP-1 receptorSmall molecule | Type 2 Diabetes |
| Phase 2 | HER3 × ErbB4Biologic (subtype unspecified) | Heart Failure | |
| Phase 2 | Endothelin receptor type A (ETA)Small molecule | Chronic Kidney Disease | |
| Phase 2 | Apolipoprotein(a) [apo(a)] / apo(a)-apoB100 interactionSmall molecule | Atherosclerotic Cardiovascular Disease | |
| Phase 2 | Aldosterone synthase (CYP11B2)Small molecule | Chronic Kidney Disease |
Upcoming events
Research
Unlock the company readout calendar
Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.
Financial reports
Research
Unlock sourced financial history
Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.